Who owns LEAP THERAPEUTICS INC?
- Ticker: LPTX
- CUSIP Number: 52187k200
Tip: Access positions for across all investors
Analyze quarterly positions in Leap Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Leap Therapeutics stock
Who bought or sold LEAP THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Balyasny Asset Management | 3.1M | $6.1M | 362% | Jun 2024 |
|
| Samsara BioCapital | 2.4M | $6.3M | 0% | Sep 2024 |
|
| 683 Capital Management | 1.4M | $3.5M | 6% | Sep 2024 |
|
| Rock Springs Capital Management | 1.3M | $2.5M | 39% | Jun 2024 |
|
| Baker Bros. Advisors | 1.2M | $3.0M | 0% | Sep 2024 |
|
| Simplify Asset Management | 1.1M | $2.7M | 67% | Sep 2024 |
|
| Vanguard Group | 996k | $2.0M | 15% | Jun 2024 |
|
| Laurion Capital Management | 709k | $1.8M | 0% | Sep 2024 |
|
| Citadel Advisors | 476k | $1.2M | -49% | Sep 2024 |
|
| Geode Capital Management | 329k | $847k | 18% | Sep 2024 |
|
| Key Client Fiduciary Advisors | 322k | $827k | 13% | Sep 2024 |
|
| BlackRock | 203k | $522k | 100% | Sep 2024 |
|
| Acadian Asset Management | 184k | $470k | -28% | Sep 2024 |
|
| BlackRock | 172k | $337k | 487% | Jun 2024 |
|
| Exome Asset Management | 103k | $264k | 100% | Sep 2024 |
|
| Dimensional Fund Advisors | 82k | $209k | 27% | Sep 2024 |
|
| State Street Corporation | 72k | $141k | 14% | Jun 2024 |
|
| Susquehanna International | 66k | $170k | 453% | Sep 2024 |
|
| Knott David M Jr | 65k | $168k | -43% | Sep 2024 |
|
| Northern Trust | 62k | $158k | 36% | Sep 2024 |
|
| Marshall Wace | 53k | $136k | -34% | Sep 2024 |
|
| Renaissance Technologies | 40k | $102k | -59% | Sep 2024 |
|
| HB Wealth Management | 25k | $65k | 100% | Sep 2024 |
|
| Two Sigma Investments | 23k | $46k | 100% | Jun 2024 |
|
| Tower Research Capital | 19k | $37k | 188% | Jun 2024 |
|
| Valence8 US | 19k | $48k | 100% | Sep 2024 |
|
| Goldman Sachs Group | 18k | $34k | -4% | Jun 2024 |
|
| American Century Companies | 11k | $29k | 0% | Sep 2024 |
|
| William Blair $ Company | 10k | $26k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 4.6k | $12k | -2% | Sep 2024 |
|
| CNB Bank | 1.5k | $3.9k | 0% | Sep 2024 |
|
| Atlantic Trust | 1.5k | $3.9k | 0% | Sep 2024 |
|
| Group One Trading | 1.4k | $3.7k | 100% | Sep 2024 |
|
| Morgan Stanley | 1.1k | $2.1k | -2% | Jun 2024 |
|
| Us Bancorp | 610.00 | $1.6k | 0% | Sep 2024 |
|
| Golden State Equity Partners | 250.00 | $642.000000 | 100% | Sep 2024 |
|
| Bank of America Corporation | 247.00 | $635.012300 | -7% | Sep 2024 |
|
| Jpmorgan Chase & Co | 227.00 | $583.004100 | 0% | Sep 2024 |
|
| Tompkins Financial Corp | 120.00 | $308.004000 | 0% | Sep 2024 |
|
| Hanson McClain Advisors | 115.00 | $295.998500 | 0% | Sep 2024 |
|
| Simplex Trading | 78.00 | $0 | 100% | Sep 2024 |
|
| Royal Bank of Canada | 25.00 | $0 | 100% | Sep 2024 |
|
| Qube Research & Technologies | 6.00 | $12.000000 | 0% | Jun 2024 |
|
| Caldwell Sutter Capital | 4.00 | $10.000000 | 0% | Sep 2024 |
|
Who sold out of Leap Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Logos Global Management | Mar 2024 | 40k | $105k |
| Jane Street | Jun 2024 | 31k | $61k |
| Squarepoint Ops | Mar 2024 | 27k | $72k |
| Millennium Management | Jun 2024 | 16k | $32k |
| CoreCap Advisors | Jun 2024 | 5.1k | $9.9k |
| Rhumbline Advisers | Jun 2024 | 24.00 | $46.999200 |